CVS Health Corporation NYSE:CVS is reporting this earnings, what to expect.

0
913

CVS Health Corporation NYSE:CVS is reporting this earnings, what to expect.

CVS Health Corporation NYSE:CVS headquartered in Chesterbrook, Pennsylvania, United States is reporting their earnings on 05/02/2018 before the bell. Street forecast for the quarter ending March 2018 is $1.39.

According to stock market daily analyst this is Lower then same time previous year. CVS Health Corporation reported EPS for the same quarter last year was $1.17.

()
()

Chart

Overview of CVS Health Corporation NYSE:CVS

CVS Health Corporation (previously CVS Corporation and CVS Caremark Corporation) (stylized as Heart corazón.svgCVSHealth) is an American retail pharmacy and health care company headquartered in Woonsocket, Rhode Island. The company began in 1964 with three partners who grew the venture from a parent company, Mark Steven, Inc., that helped retailers manage their health and beauty aid product lines. The business began as a chain of health and beauty aid stores, but within several years, pharmacies were added. To facilitate growth and expansion, the company joined The Melville Corporation, which managed a string of retail businesses. Following a period of growth in the 1980s and 1990s, CVS Corporation spun off from Melville in 1996, becoming a standalone company trading on the New York Stock Exchange as NYSE: CVS

It later completed a merger with the pharmacy benefit management company Caremark Rx in 2007 and was consequently renamed CVS Caremark Corporation. The company was renamed CVS Health in 2014 following its decision to remove tobacco products from CVS Pharmacy store shelves. CVS Health’s assets include CVS Pharmacy, CVS Caremark, CVS Specialty, and the retail clinic MinuteClinic.

In 2017, it ranked seventh on the Fortune 500 and 18th on the Fortune Global 500 list with $177B in annual revenue.In December 2017, CVS agreed to acquire Aetna for $69 billion.

CVS
Name
Change
% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Volume
Dividend Rate